Incyte Corporation Reviews Recent Progress In Multiple Programs; Announces 2006 Financial Results And 2007 Financial Guidance

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) today reviewed the Company’s recent progress and 2007 objectives for its drug discovery and development programs in HIV, diabetes, inflammation and oncology, and announced its 2006 financial results and 2007 financial guidance.

Back to news